Skip to content
The Policy VaultThe Policy Vault

Suboxone (Brand Only)United Healthcare

opioid dependence

Preferred products

  • buprenorphine/naloxone (generic Suboxone)
  • Zubsolv

Initial criteria

  • Patient is being treated for opioid dependence
  • AND BOTH of the following:
  • One of the following:
  • - Submission of medical records documenting an inadequate response to a minimum 30-day trial of Zubsolv (trial must be completed prior to PA request)
  • - OR Submission of medical records documenting adverse effects or contraindication to Zubsolv including manifestation or reason for contraindication
  • AND One of the following:
  • - Submission of medical records documenting an inadequate response to a minimum 30-day trial of buprenorphine/naloxone (generic Suboxone) (trial must be completed prior to PA request)
  • - OR Submission of medical records documenting adverse effects or contraindication to buprenorphine/naloxone (generic Suboxone) including manifestation or reason for contraindication

Reauthorization criteria

  • Documentation of positive clinical response

Approval duration

12 months